Australia Research Shows Male Bias In 300 Percent Increase In Ritalin
This article was originally published in PharmAsia News
Executive Summary
Australian authorities report a 300 percent increase in the use of Novartis's Ritalin (methylphenidate) over the past seven years, most for treating boys